| Category | BioTech |
| Phone | (617) 498-1070 |
| Employees | |
| Founded | 2007 |
| Description | Influenza Research |
| Total | $6.45M |
| Series A, 5/09 Polaris Venture Partners Flagship Ventures Lux Capital | $3.25M |
| Unattributed, 11/09 | $3.2M |
Parasol Therapeutics does research on influenza diagnostics and treatment. They were in seed/stealth stage as of June 2009.